TAIFEX continues to broaden its product lineup in the Single Stock Futures (SSFs) and ETF Futures segments. On February 3, TAIFEX listed five new SSFs, including three standard contracts on AURAS Technology (ticker symbol: UL), Alchip Technologies (UM), and Bora Pharmaceuticals Co. (UP), as well as mini contracts for the latter two—Alchip Technologies (UO) and Bora Pharmaceuticals Co. (UQ). Meanwhile, standard and mini contracts on the UPAMC NYSE FANG+ ETF Futures (UR and US) were also introduced on the same day.
The newly listed SSFs cover the semiconductor and biopharmaceutical sectors, while the ETF tracks globally traded high-tech semiconductor stocks. These additions provide investors with enhanced opportunities to participate in Taiwan’s high-growth industries while strengthening their risk management strategies.
With these new offerings, TAIFEX now offers a total of 300 SSFs (including 38 Mini SSFs, 20 ETF Futures, and 3 Mini ETF Futures), along with 48 Single Stock Options (STOs, including six ETF Options). For a complete list of available products, please visit here.
Click here for full details.
